Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Erzhu Jiedu Recipe (EZJDR) is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of hepatitis B virus-related hepatocellular carcinoma (HBV-HCC), hepatitis B cirrhosis with hyperalphafetoproteinemia, and liver precancerous lesions. EZJDR consists of multiple herbal components, with at least 138 compounds identified, including sesquiterpenoids, diterpenoids, anthraquinones, flavonoids, among others. Preclinical studies indicate that tricyclic diterpenoids from EZJDR have the highest systemic exposure and show cytotoxic effects on hepatoma cells by inducing apoptosis and cell cycle arrest via mitochondrial and p53-p21-associated signaling pathways. Clinical evidence suggests the formula can lower liver biomarkers such as alpha-fetoprotein (AFP) and has beneficial effects on liver function and disease progression in HBV-related conditions[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on erzhu jiedu recipe.